ICH Q7 Third-Party Audit Completed — Zero Critical Findings

keruihk successfully completed its annual ICH Q7 third-party compliance audit with zero critical findings and only two minor observations, both resolved within 30 days. The audit covered all 8 synthesis suites, the analytical QC laboratory, and the cold-chain logistics center.

← Back to News
Newsletter

Stay Ahead in
Peptide Science

Join 5,000+ pharmaceutical and biotech professionals who receive our monthly newsletter — covering product launches, regulatory updates, and industry insights.

  • New product launches & catalog updates
  • Regulatory news & compliance updates
  • Industry trends & market insights
  • Company milestones & partnerships

Subscribe to Our Newsletter

Monthly digest, no spam. Unsubscribe anytime.

By subscribing, you agree to our Privacy Policy. No spam, ever.